Financhill
Back

iShares JPX-Nikkei 400 ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
45

JPXN
iShares JPX-Nikkei 400 ETF

Last Price:
$86.1500
Seasonality Move:
0.25%
Sell
45

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$78.95
Seasonality Move:
-32.16%
Sell
45
iShares JPX-Nikkei 400 ETF (JPXN) is a Sell

Is iShares JPX-Nikkei 400 ETF a Buy, Sell or Hold?

  • The current iShares JPX-Nikkei 400 ETF [JPXN] share price is $85.8514. The Score for JPXN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • JPXN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences, Inc. (DRUG) is a Sell

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPXN Stock Price Chart

What is iShares JPX-Nikkei 400 ETF's stock price today?

  • The iShares JPX-Nikkei 400 ETF share price today is $85.8514
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPXN is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $78.88
    The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.

JPXN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 42.04 Sell
Chaikin Money Flow: -5862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.8114 - 88.6914) Sell
Bollinger Bands (100): (83.5358 - 88.0358) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 54.75 Buy
Chaikin Money Flow: -145421 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.39 - 83.51) Buy
Bollinger Bands (100): (41.65 - 69.37) Buy

JPXN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.94 Sell
20-day SMA: 87.4 Sell
50-day SMA: 87.14 Sell
200-day SMA: 81.02 Buy
8-day EMA: 87.31 Sell
20-day EMA: 87.5 Sell
50-day EMA: 86.95 Sell
200-day EMA: 82.19 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.2 Sell
20-day SMA: 75.43 Buy
50-day SMA: 66.05 Buy
200-day SMA: 43.03 Buy
8-day EMA: 83.79 Sell
20-day EMA: 77.26 Buy
50-day EMA: 67.4 Buy
200-day EMA: 47.62 Buy

iShares JPX-Nikkei 400 ETF Earnings Growth & JPXN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

iShares JPX-Nikkei 400 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):